Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia
暂无分享,去创建一个
J. Schuchhardt | J. Wiltfang | L. Parnetti | S. Herukka | H. Klafki | P. Spitzer | M. Otto | D. Chiasserini | H. Kamrowski-Kruck | H. Schieb
[1] Xiaojing Sui,et al. Cerebrospinal fluid biomarkers of Alzheimer’s disease , 2014, Neuroscience Bulletin.
[2] K. Blennow,et al. cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases , 2010, International journal of Alzheimer's disease.
[3] Hilkka Soininen,et al. J-ADNI and selection of cognition measures , 2010, Alzheimer's & Dementia.
[4] J. Fleming,et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking , 2009, Neurology.
[5] L. Parnetti,et al. Cerebrospinal Fluid Biomarkers and Prediction of Conversion in Patients with Mild Cognitive Impairment: 4-Year Follow-Up in a Routine Clinical Setting , 2009, TheScientificWorldJournal.
[6] W. M. van der Flier,et al. A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease , 2009, Annals of clinical biochemistry.
[7] R. Petersen,et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.
[8] H. Soininen,et al. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. , 2009, Archives of neurology.
[9] P. Lewczuk,et al. Neurochemical dementia diagnostics: State of the art and research perspectives , 2008, Proteomics.
[10] Hilkka Soininen,et al. CSF Aβ42, Tau and phosphorylated Tau, APOE ɛ4 allele and MCI type in progressive MCI , 2007, Neurobiology of Aging.
[11] Johannes Kornhuber,et al. Therapeutic approaches to Alzheimer's disease. , 2006, Brain : a journal of neurology.
[12] K. Blennow,et al. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study , 2006, The Lancet Neurology.
[13] Lucilla Parnetti,et al. Diagnosing prodromal Alzheimer's disease: Role of CSF biochemical markers , 2006, Mechanisms of Ageing and Development.
[14] R. Slack,et al. Emerging Role for ERK as a Key Regulator of Neuronal Apoptosis , 2004, Science's STKE.
[15] R. Nussbaum,et al. Alzheimer's disease and Parkinson's disease. , 2003, The New England journal of medicine.
[16] George Perry,et al. The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease , 2002, Neurosignals.
[17] J. Sweatt,et al. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory , 2001, Journal of neurochemistry.
[18] Patrick R. Hof,et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.
[19] S. Grewal,et al. Extracellular-signal-regulated kinase signalling in neurons , 1999, Current Opinion in Neurobiology.
[20] E. Goldsmith,et al. How MAP Kinases Are Regulated (*) , 1995, The Journal of Biological Chemistry.
[21] H. Braak,et al. Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.
[22] H. W. Harris,et al. Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[23] E Capitani,et al. A neuropsychological instrument adding to the description of patients with suspected cortical dementia: the Milan overall dementia assessment. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[24] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[25] H. Towbin,et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[26] S. Folstein,et al. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .
[27] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[28] R. Petersen,et al. Cognitive Impairment : An Overview By , 2013 .
[29] J. Wiltfang,et al. ERK2 is increased in cerebrospinal fluid of Creutzfeldt-Jakob disease patients. , 2010, Journal of Alzheimer's disease : JAD.
[30] F. Jessen,et al. Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated form. , 2009, Journal of Alzheimer's disease : JAD.
[31] Hilkka Soininen,et al. CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI. , 2007, Neurobiology of aging.
[32] J. Sweatt,et al. MAPK regulation of gene expression in the central nervous system. , 2000, Acta neurobiologiae experimentalis.
[33] M Haupt,et al. [Clinical diagnosis of Alzheimer's disease]. , 1988, Deutsche medizinische Wochenschrift.